Question 1

My patient has anxiety plus depression plus insomnia - which single medication addresses all three?

Accepted Answer

Mirtazapine uniquely targets all three symptoms through distinct mechanisms: H1-mediated sedation for insomnia, 5-HT2C antagonism enhancing appetite and mood, and noradrenergic/serotonergic enhancement for both depression and anxiety. The dose-sedation paradox means 7.5-15mg is most sedating; higher doses (30-45mg) show less sedation but stronger antidepressant effect. Evidence supports high response rates in anxious depression, but mirtazapine is not first-line for uncomplicated GAD. SSRIs remain first-line when depression is the primary driver and insomnia is secondary.

Question 2

When should I choose an SSRI vs mirtazapine for anxious depression?

Accepted Answer

Mirtazapine uniquely targets all three symptoms through distinct mechanisms: H1-mediated sedation for insomnia, 5-HT2C antagonism enhancing appetite and mood, and noradrenergic/serotonergic enhancement for both depression and anxiety. The dose-sedation paradox means 7.5-15mg is most sedating; higher doses (30-45mg) show less sedation but stronger antidepressant effect. Evidence supports high response rates in anxious depression, but mirtazapine is not first-line for uncomplicated GAD. SSRIs remain first-line when depression is the primary driver and insomnia is secondary.

Question 3

Does the comorbidity profile drive agent selection more than efficacy data?

Accepted Answer

Mirtazapine uniquely targets all three symptoms through distinct mechanisms: H1-mediated sedation for insomnia, 5-HT2C antagonism enhancing appetite and mood, and noradrenergic/serotonergic enhancement for both depression and anxiety. The dose-sedation paradox means 7.5-15mg is most sedating; higher doses (30-45mg) show less sedation but stronger antidepressant effect. Evidence supports high response rates in anxious depression, but mirtazapine is not first-line for uncomplicated GAD. SSRIs remain first-line when depression is the primary driver and insomnia is secondary.

Question 4

Should I use one medication for everything or combine agents targeting each symptom?

Accepted Answer

Mirtazapine uniquely targets all three symptoms through distinct mechanisms: H1-mediated sedation for insomnia, 5-HT2C antagonism enhancing appetite and mood, and noradrenergic/serotonergic enhancement for both depression and anxiety. The dose-sedation paradox means 7.5-15mg is most sedating; higher doses (30-45mg) show less sedation but stronger antidepressant effect. Evidence supports high response rates in anxious depression, but mirtazapine is not first-line for uncomplicated GAD. SSRIs remain first-line when depression is the primary driver and insomnia is secondary.

PsychHQ

Mirtazapine for Anxious Depression with Insomnia: When One Agent Addresses All Three